Insider Transactions in Q2 2025 at Cme Group Inc. (CME)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 22
2025
|
Daniel G Kaye Director |
SELL
Open market or private sale
|
Direct |
500
-12.0%
|
$141,000
$282.42 P/Share
|
|
May 20
2025
|
Jonathan L Marcus Sr MD General Counsel |
SELL
Open market or private sale
|
Direct |
390
-5.49%
|
$108,030
$277.5 P/Share
|
|
May 19
2025
|
Phyllis M Lockett Director |
SELL
Open market or private sale
|
Direct |
1,060
-25.43%
|
$293,620
$277.88 P/Share
|
|
May 15
2025
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
300
-1.2%
|
$81,900
$273.17 P/Share
|
|
May 15
2025
|
Charles P Carey Director |
SELL
Open market or private sale
|
Indirect |
3,000
-35.71%
|
$816,000
$272.56 P/Share
|
|
May 05
2025
|
Derek Sammann Sr MD Gl Hd Commodities Mkts |
SELL
Open market or private sale
|
Indirect |
4,650
-17.92%
|
$1,302,000
$280.62 P/Share
|
|
Apr 29
2025
|
Dennis Suskind Director |
SELL
Open market or private sale
|
Direct |
1,000
-25.54%
|
$271,000
$271.28 P/Share
|
|
Apr 25
2025
|
Larry G Gerdes Director |
SELL
Open market or private sale
|
Direct |
2,000
-5.17%
|
$532,000
$266.12 P/Share
|
|
Apr 24
2025
|
Larry G Gerdes Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.49%
|
$528,000
$264.1 P/Share
|